RedHill Biopharma reported $-1540000 in Net Income for its fiscal quarter ending in June of 2024.


Net Income Change Date
Clal Biotechnology ILS -6166000 15.56M Dec/2022
Compugen USD -7340000 1.22M Jun/2025
Cronos Group USD -39711000 45.83M Jun/2025
RedHill Biopharma USD -1540000 0 Jun/2024